Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-13-001018
Filing Date
2013-09-17
Accepted
2013-09-17 11:27:18
Documents
1
Period of Report
2013-09-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 8562
  Complete submission text file 0000904454-13-001018.txt   11304
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address 575 HIGH STREET, SUITE 201 PALP ALTO CALIFORNIA CA 94301
Business Address 575 HIGH STREET, SUITE 201 PALP ALTO CALIFORNIA CA 94301
VIVO VENTURES VI AFFIILATES FUND, L.P. (Reporting) CIK: 0001400245 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 131100424

Mailing Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301
Business Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures Fund VI, L.P. (Reporting) CIK: 0001469473 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 131100425

Mailing Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301
Business Address 575 HIGH STREET, SUITE 201 PALO ALTO CA 94301 (650) 688-0818
Vivo Ventures VI, LLC (Reporting) CIK: 0001469547 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 131100426